Growth Of Tumors In Human Cell Lines Slowed By Synthetic Cocoa Chemical
A synthetic chemical based on a compound found in cocoa beans slowed growth and accelerated destruction of human tumors in laboratory studies, and should be tested further for cancer chemoprevention or even treatment, say researchers at Georgetown University Medical Center.
Oncology Scientific And Educational Conference And Cancer Patient Seminar: ESMO 2008
ESMO Conference July 3-6, 2008 -- Lugano, Switzerland.Following the success of the 2007 ECLU Conference, the European Society for Medical Oncology (ESMO) will host around 600 doctors and researchers at a four-day meeting featuring highlights presentations on the most common tumor types plus educational sessions addressing key issues such as cancer and pregnancy, human papillomavirus vaccines, cancer stem cells and biomarkers.
Scottish Patients With Chronic Myeloid Leukaemia Gain Access To New Treatment
The Scottish Medicines Consortium (SMC) announced that Tasigna (nilotinib) is accepted for use within NHS Scotland for treatment of adult patients with Philadelphia positive (Ph+) chronic myelogenous leukaemia (CML), who are resistant to or intolerant of at least one prior therapy including Glivec (imatinib), in the early phase of the disease.
Health Economic Analysis Reports That Revlimid Is A Cost Effective Treatment For Multiple Myeloma
Celgene International Sarl (Nasdaq:CELG) announced that data presented at the 13th Congress of the European Hematology Association (EHA) in Copenhagen, Denmark found that patients previously treated for multiple myeloma receiving REVLIMID (lenalidomide) in combination with dexamethasone experienced a significant survival gain regardless of the number of prior therapies they had received.
Mechanism That Prevents Cells From Transforming Into Cancer Cells
MRC scientists have discovered a mechanism that prevents cells from transforming into cancer cells. As cells age they enter a state called senescence, a kind of suspended animation that allows a cell to keep functioning but prevents it from changing.
How Inflammatory Proteins Can Protect Against Cancer
Our body has a better way of protecting itself against cancer than previously recognised. Inflammatory proteins help to prevent the progression of a benign tumour to a malignant one. This is reported by Dr. Daniel Peeper and his colleagues from the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) in the June 13 issue of the prominent scientific journal Cell.
Spring Into Sunny Weather But Stay Sun Safe
As the weather grows warmer, people's thoughts turn to outdoor activities and enjoying the sunshine. Dana-Farber Cancer Institute physicians and nurses are encouraging people when they are outside, whether they are spending a day at the beach or a few hours working in their yard, to be aware of the dangers of overexposure to the sun and to practice sun safety.
Comment From Breakthrough Breast Cancer Re Today's Breast Screening Story
Comment From Breakthrough Breast Cancer Re Screen Detected Breast Cancer Patients Match Life Expectancy Of General Female Population Dr Alexis Willett from Breakthrough Breast Cancer says: "It's excellent news that women with early breast cancer found through screening can live as long as those never affected by the disease.
GPC Biotech Announces Granting Of European Patent Related To Satraplatin For Treating Tumors Resistant Or Refractory To Taxanes
GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral platinum compound. The patent is entitled, "Satraplatin for treating resistant or refractory tumors" and covers certain uses of satraplatin related to the treatment of a cancer or tumor resistant or refractory to a taxane, including docetaxel (Taxotere ) and paclitaxel (Taxol ).
ESMO Conference Lugano ECLU - Oncology Scientific And Educational Conference And Cancer Patient Seminar
Cancer experts and patients are gathering in Switzerland next month for the 2nd ESMO Conference Lugano (ECLU), where they will discuss the latest advances in the treatment and prevention of diseases that affect millions of people worldwide.